Glucosamine Complex
Glucosamine Complex, licence 80076532: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- 3 in 1 Joint Complex
- Licence holder
- Richwin Toronto Corporation
- NPN or DIN-HM
- 80076532
- Status
- Active licence
- Licence date
- 4 April 2017
- Revision date
- 7 March 2023
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crevettes | 500.0 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de crabes | 500.0 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de pottasium provenant d¿exosquelettes de homards | 500.0 milligramme | Not calculated |
| Sulfate de chondroïtine Source : Bos taurus - cartilage | 200.0 milligramme | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 200.0 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis (of the knee). Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If symptoms worsen, consult a health care practitioner.
Source
Official Health Canada record, licence 80076532
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.